Literature DB >> 14966914

Expression of thymidine phosphorylase by macrophages in colorectal cancer tissues.

Ji-Min Zhang1, Takayuki Mizoi, Ken-Ichi Shiiba, Iwao Sasaki, Seiki Matsuno.   

Abstract

AIM: To detect the thymidine phosphorylase (dThdPase) expression in human colorectal cancer tissues and cells.
METHODS: Forty specimens resected from patients with colorectal cancer were immunohistochemically stained by 654-1, anti-dThdPase monoclonal antibody, PG-M1, anti-macrophage marker CD68 monoclonal antibody. Morphometrical analysis and positive cell counting were performed. In 27 of 40 specimens, dThdPase activity was also assayed by HPLC. Otherwise, the dThdPase level was measured by ELISA in 6 colorectal cancer cell lines, LS174T, Clone A, Colo320, CX-1, Lovo, and MIP101, as well as in 2 macrophage-like cell lines, THP-1 and U937.
RESULTS: dThdPase activity was significantly increased in cancer tissues compared with adjacent normal tissue (P<0.01). In immunohistochemical analysis, it was confirmed that most cells expressed dThdPase were the stromal cells surrounding cancer nests or along the invasive margin of cancer. Based on their morphometrical characteristics, we found that most of them were tumor-associated macrophages (TAMs). The number of dThdPase-positive stromal cells was significantly correlated with the number of CD68-positive macrophages (r=0.76, P<0.0001). By ELISA, 18.2 unit/mg and 19.3 unit/mg of dThdPase protein were detected in THP-1 and U937, but only little was detected in 6 colorectal cancer cell lines.
CONCLUSION: The present data suggest that dThdPase expression is seldom detected in colorectal carcinoma cells. TAM is the most important source of dThdPase in colorectal cancer tissues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966914      PMCID: PMC4716977          DOI: 10.3748/wjg.v10.i4.545

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  PyNPase expression in human colon cancer.

Authors:  A Haba; T Monden; M Sekimoto; K Ikeda; H Izawa; T Kanou; M Amano; H Kan'yama; M Monden
Journal:  Cancer Lett       Date:  1998-01-09       Impact factor: 8.679

2.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

3.  Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer.

Authors:  H Amaya; N Tanigawa; C Lu; M Matsumura; T Shimomatsuya; T Horiuchi; R Muraoka
Journal:  Cancer Lett       Date:  1997-11-11       Impact factor: 8.679

4.  Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.

Authors:  R D Armstrong; R B Diasio
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

5.  Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues.

Authors:  M Nishida; A Hino; K Mori; T Matsumoto; T Yoshikubo; H Ishitsuka
Journal:  Biol Pharm Bull       Date:  1996-11       Impact factor: 2.233

6.  Purification and properties of an endothelial cell growth factor from human platelets.

Authors:  K Miyazono; T Okabe; A Urabe; F Takaku; C H Heldin
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

7.  Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumor angiogenesis and macrophage infiltration in colorectal cancer.

Authors:  M Matsumura; Y Chiba; C Lu; H Amaya; T Shimomatsuya; T Horiuchi; R Muraoka; N Tanigawa
Journal:  Cancer Lett       Date:  1998-06-05       Impact factor: 8.679

8.  Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase.

Authors:  K Miyadera; T Sumizawa; M Haraguchi; H Yoshida; W Konstanty; Y Yamada; S Akiyama
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

9.  Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study.

Authors:  S B Fox; A Moghaddam; M Westwood; H Turley; R Bicknell; K C Gatter; A L Harris
Journal:  J Pathol       Date:  1995-06       Impact factor: 7.996

10.  Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3.

Authors:  H Schwende; E Fitzke; P Ambs; P Dieter
Journal:  J Leukoc Biol       Date:  1996-04       Impact factor: 4.962

View more
  3 in total

Review 1.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

2.  Research development of the relationship between thymidine phosphorylase expression and colorectal carcinoma.

Authors:  Dian-Jun Ye; Ji-Min Zhang
Journal:  Cancer Biol Med       Date:  2013-03       Impact factor: 4.248

3.  Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli.

Authors:  Ismail Seckin; Mumin Uzunalan; Meltem Pekpak; Sibel Kokturk; Huseyin Sonmez; Zeynep Oztürk; Sibel Demirci; Elif Yaprak
Journal:  J Biomed Sci       Date:  2012-02-16       Impact factor: 8.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.